Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.
J Clin Oncol
; 21(14): 2645-50, 2003 Jul 15.
Article
en En
| MEDLINE
| ID: mdl-12860939
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Sulfonamidas
/
Carboplatino
/
Inhibidores de la Ciclooxigenasa
/
Paclitaxel
/
Carcinoma de Pulmón de Células no Pequeñas
/
Neoplasias Pulmonares
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2003
Tipo del documento:
Article